Cargando…
Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine
The E2 glycoprotein of hepatitis C virus (HCV) is the major target of broadly neutralizing antibodies (bNAbs) that are critical for the efficacy of a prophylactic HCV vaccine. We previously showed that a cell culture–derived, disulfide-linked high-molecular-weight (HMW) form of the E2 receptor–bindi...
Autores principales: | Center, Rob J., Boo, Irene, Phu, Lilian, McGregor, Joey, Poumbourios, Pantelis, Drummer, Heidi E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247312/ https://www.ncbi.nlm.nih.gov/pubmed/32299914 http://dx.doi.org/10.1074/jbc.RA120.013015 |
Ejemplares similares
-
Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs
por: McGregor, Joey, et al.
Publicado: (2022) -
A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice
por: Donnison, Timothy, et al.
Publicado: (2022) -
Hepatitis C Virus (HCV) Envelope Glycoproteins E1 and E2 Contain Reduced Cysteine Residues Essential for Virus Entry
por: Fraser, Johanna, et al.
Publicado: (2011) -
The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs
por: Vietheer, Patricia T., et al.
Publicado: (2017) -
Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region
por: Alhammad, Yousef, et al.
Publicado: (2015)